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ABSTRACT  Seven polypeptides  (a, b, c,  1, 2, 3a, and  3b)  have  been previously  identified  as 
tropomyosin  isoforms  in  chicken  embryo fibroblasts  (CEF) (Lin, J. J.-C., Matsumura,  F., and 
Yamashiro-Matsumura, S., 1984, J. Cell. Biol., 98:116-127). Spots a and c had identical mobility 
on two-dimensional gels with the slow-migrating and fast-migrating  components, respectively, 
of chicken gizzard tropomyosin.  However, the remaining isoforms  of CEF tropomyosin were 
distinct from chicken skeletal and cardiac tropomyosins on two-dimensional gels. The mixture 
of CEF tropomyosin  has  been  isolated  by the  combination  of Triton/glycerol  extraction  of 
monolayer cells,  heat treatment, and ammonium sulfate  fractionation.  The yield of tropomy- 
osin was estimated to be 1.4% of total CEF proteins. The identical set of tropomyosin isoforms 
could  be  found  in  the  antitropomyosin  immunoprecipitates  after  the  cell-free  translation 
products  of total  poly(A)  ÷ RNAs  isolated  from  CEF cells.  This  suggested  that at  least seven 
mRNAs  coding  for  these  tropomyosin  isoforms  existed  in  the  cell.  Purified  tropomyosins 
(particularly  1, 2, and  3) showed different actin-binding abilities  in the presence  of 100 mM 
KCI and no divalent cation.  Under this condition,  the binding of tropomyosin  3 (3a +  3b) to 
actin filaments was significantly  weaker than that of tropomyosin  1 or 2. CEF tropomyosin  1, 
and probably 3, could be cross-linked  to form homodimers by treatment with 5,5'-dithiobis- 
(2-nitrobenzoate), whereas tropomyosin a and c formed a heterodimer. These dimer species 
may reflect the in vivo assembly of tropomyosin isoforms,  since dimer formation occurred not 
only  with  purified  tropomyosin  but  also with  microfilament-associated  tropomyosin.  The 
expression  of these tropomyosin  isoforms  in  Rous sarcoma  virus-transformed  CEF cells  has 
also been  investigated.  In agreement with the previous  report by Hendricks and  Weintraub 
(Proc. Natl. Acad. Sci. USA.,  78:5633-5637), we found that major tropomyosin  1 was greatly 
reduced  in transformed  cells.  We have also found that the relative  amounts of tropomyosin 
3a  and  3b  were  increased  in  both  the  total  cell  lysate  and  the  microfilament  fraction  of 
transformed  cells.  Because of the different actin-binding  properties observed  for CEF tropo- 
myosins,  changes  in  the  expression  of these  isoforms  may,  in  part,  be  responsible  for the 
reduction of actin cables and the alteration of cell shape found in transformed cells. 
Tropomyosin is a ubiquitous protein associated with the thin 
filaments of muscle cells and  with  microfilaments  of non- 
muscle cells. In striated muscles, tropomyosin together with 
the troponin complex regulates the actin-myosin interaction 
in  a  calcium-dependent  manner  (50,  54).  However,  as  no 
troponin-like  protein  has  been  detected  so  far  in  smooth 
muscle or nonmuscle cells,  tropomyosin in these cells may 
not function  in this way. Nonmuscle forms of tropomyosin 
have been isolated from human  platelets (8),  chicken  brain 
(19), calf brain,  pancreas, and platelets (18), Physarum (28), 
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platelets (11),  equine platelets (10),  and rabbit lung macro- 
phages (16).  The  reported molecular weights of these  non- 
muscle tropomyosins range from 29,000 to 35,000. Recently, 
multiple forms (or isoforms) of tropomyosin have been de- 
tected within a single culture of nonmuscle cells (21, 24, 35, 
49,  53).  By using our microfilament isolation method (42), 
we have previously detected at least five isoforms of tropo- 
myosin from rat, mouse, and human fibroblasts (38, 42), and 
seven isoforms of tropomyosin from chicken embryo fibro- 
blasts (CEF) l (37). The function and assembly of these mul- 
tiple forms of tropomyosin are not yet understood. However, 
different forms of tropomyosin may play different roles in 
stabilizing and protecting actin-microfilaments in nonmuscle 
cells (3,  16, 24, 35, 38, 41). 
In this report, we have extended our studies on the signifi- 
cance of tropomyosin isoforms by purifying seven forms of 
tropomyosin from CEF and by characterizing them in terms 
of their actin-binding properties and dimer formation. Differ- 
ent actin-binding properties for major and minor isoforms of 
CEF tropomyosin were observed. 
Changes in the expression of tropomyosin isoforms have 
been  previously reported to occur in  many types of trans- 
formed cells,  including cells transformed by DNA  or RNA 
viruses, by chemical carcinogens, or ultraviolet irradiation, or 
by transfection with tumor DNA (38,  41). The general phe- 
nomena in  these changes is that at least  one of the major 
tropomyosin  isoforms  with  a  higher  apparent  molecular 
weight appears to be decreased or missing, and the level of at 
least one of the tropomyosin isoforms with a lower apparent 
molecular weight tends to be increased in all types of trans- 
formed  cells.  In  this  report,  we  also  studied  tropomyosin 
alterations in transformed CEF cells.  In addition to the re- 
duction of major tropomyosin in Rous sarcoma virus (RSV)- 
transformed CEF cells reported by Hendricks and Weintraub 
(24),  we  found  that  the  levels  of minor  tropomyosin  are 
increased.  This is in  agreement with the general pattern of 
tropomyosin isoform changes  in  transformed cells that we 
have previously reported (38, 41). 
MATERIALS  AND  METHODS 
Cell Culture:  Primary cultures of CEF were prepared from  10-d-old 
embryos as described  previously (37).  Cells were maintained in  Dulbecco's 
modified Eagle's  medium containing 10%  fetal  calf serum and incubated at 
37°C in a humidified incubator with 5% CO2 and 95% air. High titer stocks of 
RSV were used to infect CEF cells.  Morphological transformation of CEF cells 
was evident at 3-4 d after infection. 
Purification of  Tropomyosin Isoforms:  Muscle  tropomyosins 
were purified from chicken leg, heart, and gizzard by a modification of Bailey's 
method (2).  Briefly,  muscle (20 grams) was homogenized in 200 ml of l0 mM 
Tris,  pH 8.0,  0.1  M  KCI,  2  mM EGTA, and 2  mM dithiothreitol (DTT) at 
4°C.  After centrifugation at  10,000 g  for  l0  min, the pellets were extracted 
twice with 200 ml each of l0 mM Tris, pH 8.0,  l  M KCI, 2 mM EGTA, and 
2  mM DTT for  l  h at 4°C.  The extracts were collected by centrifugation at 
10,000 g  for  l0  min and boiled for  10  min. After being cooled on ice, the 
precipitates  were removed by  centrifugation at  12,000  g  for  l0  min.  The 
supernatants containing tropomyosin were fractionated by ammonium sulfate 
with a concentration between 28 and 36 g/per 100 ml of the supernatant. The 
final tropomyosins were dialyzed extensively against l0 mM Tris,  pH 8.0, 0.2 
mM DTT, and 2 mM EDTA. 
The CEF tropomyosin mixture was purified by a method similar to that for 
the isolation of microfilaments from CEF cells (37).  Briefly,  monolayer cells 
IAbbreviations used in this paper.  CEF, chicken embryo fibroblasts; 
DTNB,  5,5'-dithiobis (2-nitrobenzoate); DTT,  dithiothreitol; RSV, 
Rous sarcoma virus. 
(20  100-mm  dishes) at confluence were treated with Triton/glycerol solution 
(0.05%  Triton X-100  in 0.1  M PIPES,  5 mM MgCI2, 0.2  mM EGTA,  4  M 
glycerol) for 2 rain at room temperature. After being washed three times with 
PBS containing  5 mM MgCI2  and 0.2 mM EGTA, the Triton/glycerol-insoluble 
residues were collected in a minimal volume (2-3 ml). ATP and phenylmeth- 
ylsulfonyl  fluoride were added to give a final concentration of 5 mM each. The 
Triton/glycerol-insoluble  residues were homogenized by 30 strokes in a motor- 
driven (glass/Teflon)  homogenizer (Wheaton Scientific, Millville, N  J) at a 3.2 
setting.  After centrifugation of the homogenates at  12,800 g  for  15  min to 
remove most of the intermediate filaments and nuclei (Pellet-I), the superna- 
tants (Sup-l) were heated at 100*C for  10 min. After being cooled on ice, the 
precipitates were removed by centrifugation at 12,800 g for 10 min. The final 
supernatants (Sup-2)  containing tropomyosin mixture were  kept  frozen  at 
-70"C and accumulated to a large volume (-30 ml). The pooled Sup-2 was 
fractionated and dialyzed by the method given above for muscle tropomyosin 
purification. 
Purification of Rabbit Skeletal Muscle F-Actin and Actin- 
binding  Assay:  Acetone powder of rabbit skeletal  muscle was prepared 
as described  by Ebashi and Ebashi  (13).  Skeletal  muscle actin was extracted 
from  this acetone powder for  l  h  at 0°C  with 30  vol of cold water.  After 
addition of 3 M KCI to a final concentration of 30 mM, actin was allowed to 
polymerize overnight at 4°C. F-actin  was collected by centrifugation (100,000 
g, 2 h) and treated with 0.6  M KCI according to the method of Spudich and 
Watt (51 ). Again, the actin pellet was collected by centrifugation  ( 100,000 g, 2 
h) and washed once with 0.1  M KCI. The final F-actin was suspended in a 0. l 
M KCI solution at a concentration of-5 mg/ml and used for the actin-binding 
assay. 
The actin-binding  assay was based on the co-sedimentation method ( 12, 25, 
31) and performed  on a  Beckman airfuge  rotor A-100/18 (Beckman Instru- 
ments,  Inc.,  Palo Alto.  CA).  Actin (100  vg) and  tropomyosin (17  ~g) were 
mixed in  175 #l of l0 mM Tris, pH 8.0, 0.2 mM DTT with various amounts 
of Mg  ÷+ and KCI and incubated at room temperature for 30 min. The mixtures 
were centrifuged  for 30  min in a  Beckman airfuge  at 26 psi to separate the 
bound and  unbound tropomyosin. Aliquots of the supernatants and  pellets 
were analyzed on  12.5% SDS polyacrylamide  gels. 
Preparation of Antibodies  and Isolation of Microfilaments: 
Methods for  preparing and characterizing rabbit antiserum against chicken 
gizzard tropomyosin were described  in a previous report (42). This antiserum 
recognized  all  isoforms of tropomyosin  from  CEF  cells.  Antitropomyosin 
monoclonal antibody LCKI6  was prepared and  characterized as described 
previously  (36). 
As reported previously, ascites fluid of LCK 16 antibody was suitable for the 
isolation of tropomyosin-enriched microfilaments from various cultured cells 
(37, 38, 41, 42). The tropomyosin-enriched microfllaments  were isolated from 
normal and RSV-transformed  CEF cells as described (37). The yield of isolated 
microfilaments  was estimated from [aSS]methionine-labeled cells and expressed 
as the actin content. Cells on 100-mm dish were labeled in vivo for  15 h with 
250  gCi  of 13SS]methionine (l,100  Ci/mmol) in  3  ml  of methionine-free 
Dulbecco's modified Eagle's medium containing 2.5%  fetal  calf serum and 
subjected to the isolation  of the tropomyosin-enriched  microfilaments.  Aliquots 
of samples from each step of the isolation procedure were analyzed on 12.5% 
SDS polyacrylamide  gels. After staining.and destaining, gels were then dried on 
filter papers.  The actin bands of each fraction were cut out and sliced to a  l- 
mm thickness.  Each slice was immersed in 0.2 ml of 2% SDS for 24 h to elute 
the radiolabeled protein. After addition of 4  ml of Aquasol (New  England 
Nuclear,  Boston, MA), the radioactivity  was measured in a liquid scintillation 
counter. The radioactivities  of tropomyosin isoforms associated with the iso- 
lated microfllaments were  also obtained by a  similar method and  used  for 
calculating  the ratios of tropomyosin isoforms to 100 parts of actin. 
Dimer Formation of Tropomyosin Isoforms:  The tropomyosin 
dimer was formed  as a  result of intramolecular cross-linking  by oxidation of 
opposing  cysteines  in  tropomyosin  with  5,5'-dithiobis  (2-nitrobenzoate) 
(DTNB) (6, 32). The 0. l M stock solution of DTNB was prepared as described 
previously by  Lehrer  (32).  Purified tropomyosins (0.2-0.5  mg/ml) or  the 
isolated microfilaments  in PBS that contained 5 mM Mg  ÷÷ and 0.2 mM EGTA 
were reacted with l0 mM DTNB for 30 min at room temperature. After the 
reaction was complete, samples were solubilized in  SDS  gel sample buffer 
without reducing agents and analyzed on  12.5% SDS polyacrylamide gel. In 
order to identify which isoforms were capable of forming dimers, we cut out 
the gel track from a one-dimensional  gel and placed it on the top of a new SDS 
polyacrylamide slab gel. This second dimension gel was run under reducing 
conditions by overlaying the gel track with SDS gel sample buffer  containing 
100 mM DTT and 1% agarose. 
Other  Biochemical  Procedures:  One-dimensional SDS  PAGE 
was carried  out  according to  Laemmli  (30)  with  a  low  concentration  of 
bisacrylamide  (12.5 % acrylamide and 0.104% hisacrylamide)  (4). Two-dimen- 
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of O'Farrell (46). The first-dimensional gels contained 4% polyacrylamide and 
pH 4-6 ampholytes. The second-dimensional gels were 12.5% SDS polyacryl- 
amide slab gels with a low concentration of bisacrylamide. For autoradiography 
and fluorography of the gel, a modified method of Bonner and kaskey (5),was 
performed as described previously (37). Protein concentration was determined 
by the method of Lowry et al. (39) with BSA as standard. 
Total cellular RNA was prepared from CEF cells by a modification (17) of 
the quanidine/hot phenol method (7). Oligo (dT)-cellulose  columns were used 
to prepare poly (A)  + RNA from the total cellular RNA (1). Poly(A) ÷ RNA was 
translated in a micrococcal nuclease-treated rabbit reticulocyte lysate (47). The 
in vitro translational products were solubilized in SDS gel sample buffer and 
analyzed by immunoprecipitation and by SDS PAGE. Immunoprecipitation 
with rabbit antiserum against tropomyosin was carried out as described previ- 
ously (42) in the buffer containing 50  mM Tris, pH 8.0,  0.05%  SDS, 0.5% 
Triton X-100,  l  mM EDTA,  l  mM phenylmethylsulfonyl fluoride, and  100 
mM NaCl. 
TABLE  I 
Total Protein Distribution  during Purification of Tropomyosin 
from CEF Cells 
Total  Percent 
Fraction  protein  of total 
mg 
Triton/glycerol extract  1.5  19.0 
Triton/glycerol-insoluble  residues  6.4  81.0 
Sup-1  2.4  30.4 
Pellet-1  3.0  38.0 
Sup-2  0.7  8.9 
28-36% ammonium sulfate  0.12  1.5 
The total protein recovered in each fraction during purification was calculated 
for the initial contents of twenty lO0-mm dishes of confluent CEF culture. 
RESULTS 
Tropomyosin Isoforms from CEF 
The procedure used here for the isolation of CEF tropo- 
myosin is similar to the microfilament isolation method we 
previously described (37,  42).  It should be applicable to the 
isolation of tropomyosin from a variety of different cultured 
cells  from  which  the  initial  materials  for  purification  are 
relatively limited. 
As Table I shows, -20% of the total protein was removed 
by Triton/glycerol extraction of monolayer cells. However, as 
judged by SDS PAGE, no significant amounts oftropomyosin 
were extracted from CEF cells by this Triton/glycerol solution 
(containing 0.05% Triton X-100). The Triton/glycerol-insol- 
uble  residues  were  homogenized  in  5  mM  Mg÷÷-ATP to 
disperse the  microfilaments. After low-speed centrifugation 
(12,800 g for 15 min), -30% of the total protein remained in 
the supernatant (Sup- 1). The pellet (pellet- 1) contained major 
proteins for the intermediate filaments and nuclei (Fig. 1, lane 
C). Very little tropomyosin was lost in this pellet-1  fraction, 
as judged by gel analysis; Heat treatment (100*C,  10 min) of 
Sup-1  precipitated many contaminant proteins and left tro- 
pomyosin in the soluble fraction (Sup-2). Tropomyosin was 
greatly enriched in this Sup-2 fraction (Fig.  1, Lane D), which 
contained 9% of the total protein. Tropomyosin in the Sup-2 
was further fractionated into the fraction between 28 and 36 
grams of ammonium sulfate/100 ml of the Sup-2. A substan- 
tial amount of tropomyosin (120 ug) with a purity >90% was 
obtained from twenty  100-mm culture dishes (Table I and 
Fig. 1, lanes G and H). Therefore, the amount of tropomyosin 
obtained was estimated as  1.4% of total proteins after cor- 
recting for impurities. 
Tropomyosin  purified  from  CEF  cells  migrated  as  five 
components  on  one-dimensional  SDS  polyacrylamide gels 
(Fig.  1,  lanes  G  and  H  and  Fig.  2A,  lane  CEF). These 
tropomyosin isoforms, which we have called a, b, 1, 2, and 3 
(37), had relative molecular weights of  45,000, 43,000, 38,000, 
36,500,  and 32,800,  respectively. Tropomyosin 1 and 2 were 
considered the major forms. These differed from tropomyosin 
isoforms purified from chicken leg muscle, gizzard, and heart 
in  their  mobilities  on  SDS  polyacrylamide gel  (Fig.  2A). 
Tropomyosin a, b, and 3 were relatively minor forms. Tro- 
pomyosin 3 was further separated into 2 components (3a and 
3b) on two-dimensional gels (Fig.  2B).  In addition, another 
component,  tropomyosin c,  was distinguished  from tropo- 
myosin  1 on  two-dimensional gels.  In the  previous report 
(37), we provided evidence demonstrating that these compo- 
nents (a, b, c,  1, 2,  3a,  and 3b) were tropomyosin isoforms: 
(a) they were immunologically cross-reacting with both poly- 
clonal and monoclonal antibodies against gizzard tropomy- 
osin; (b) they contained neither tryptophan nor proline; (c) 
they  were  associated  with  the  actin-containing  microfil- 
aments;  and  (d)  they  were  resistant  to  heat  denaturation 
(100°C,  10 min). By performing two-dimensional gel analyses 
with mixed tropomyosin samples, we were able to compare 
the mobilities of tropomyosin isoforms from chicken skeletal 
muscle, smooth muscle (gizzard),  cardiac muscle, and CEF 
cells.  Fig.  3 shows a  schematic drawing of tropomyosin iso- 
forms from chicken on two-dimensional gels. The mobilities 
of skeletal muscle tropomyosin (a-CL and ~-CL) and cardiac 
tropomyosin (CH) were different from those of CEF tropo- 
myosins, whereas the slow- and fast-migrating components of 
gizzard tropomyosin appear to  have identical mobilities to 
tropomyosin  a  and  c,  respectively.  Therefore,  at  least  10 
tropomyosin isoforms could be detected from chicken mate- 
rial  by  our  gel  system.  It  should  be  mentioned  that  the 
phosphorylated variants of skeletal muscle tropomyosin and 
cardiac muscle tropomyosin, as reported by Montarras et al. 
(44, 45), were not included here. 
To examine whether any of the CEF tropomyosin isoforms 
have resulted from the posttranslational modification of any 
other, we carried out experiments including  [32p]phosphate 
labeling, cell-free translation, and pulse-chase labeling. Anal- 
yses of the immunoprecipitates of 32p-labeled CEF cell extract 
with antitropomyosin antiserum and the microfilaments iso- 
lated from 32p-labeled cells have led us to suggest  that CEF 
tropomyosin isoforms most likely contain no phosphate (data 
not shown). As Fig. 4 shows, rabbit antigizzard tropomyosin 
antiserum is able to precipitate five protein bands from the in 
vitro translational  products of total poly(A)  ÷ RNA  isolated 
from CEF cells. These five protein bands produced a pattern 
on  a  two-dimensional gel  identical  to  that  obtained  either 
from the purified CEF tropomyosin or from the tropomyosin 
associated with  microfilaments (data  not  shown).  Thus,  at 
least seven mRNAs are present  for these tropomyosin iso- 
forms in CEF cells. Furthermore, the result from pulse-chase 
experiments showed that the rates of synthesis of the tropo- 
myosin isoforms were very similar (37), suggesting no precur- 
sor-product relationships. 
Characterization of CEF Tropomyosin Isoforms 
ACTIN-BINDING ABILITY; All  binding  experiments  were 
carried out at a  molar ratio of CEF tropomyosin to rabbit 
skeletal F-actin of 1:9 in order to obtain complete binding. 
This ratio was chosen based on the results (a) from in vitro 
binding  assays,  in  which  the  molar  ratios  of muscle  and 
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(A) Homogenate of Triton/glycerol-insoluble  residues, 34 ~g; (B) Sup-l, the supernatant fraction after the removal of nuclei and 
intermediate filaments from the homogenate by low speed centrifugation  (12,800 g, 15 min), 12 pg; (C) pellet-I, the precipitate 
of the homogenate by low speed centrifugation,  15 pg; (D) Sup-2, the supernatant fraction after the removal of heat-denatured 
(100"C,  10 rain) proteins [rom Sup-1 by low-speed centrifugation  (12,800 g, 10 min), 2/zg; (/~) the supernatant after fractionation 
of Sup-2 with 36 grams of ammonium sulfate/100 ml, 1.2 #g; (F) the pellet after fractionation of Sup-2 with 28 grams of ammonium 
sulfate/100 ml, 3.2 pg; (G and /-/) 28-36% ammonium sulfate, the fraction  between 28 and 36 grams of ammonium sulfate/100 
ml of Sup-2 solution,  3.5 pg in G, 7.5 pg in H; they were obtained from different preparations. (Std) Molecular weight marker 
proteins (Mr x  10-3). CEF tropomyosin isoforms are indicated by a, b, 1, 2, and 3. 
nonmuscle tropomyosin to actin are 1:7 and 1:6, respectively, 
at the maximal binding condition; and (b) from the previous 
analysis of the tropomyosin-enriched microfilaments isolated 
from CEF cells, in which the molar ratio is 1:7-8 (37). Thus, 
the  1:9 ratio should give complete binding. After centrifug- 
tion, the bound tropomyosin should co-sediment with F-actin 
filaments in the pellet fraction (Fig.  5, lanes B, D, F, H, J, 
and L) whereas the unbound tropomyosin should remain in 
the supernatants (Fig.  5, lanes A, C, E, G,/, and K). When 
purified  tropomyosin  was  mixed  with  actin  at  a  low  salt 
concentration (30 mM KC1) in the absence of  divalent cations, 
none of tropomyosin isoforms was able to bind to  F-actin 
(Fig.  5, lanes A and B), as was expected for skeletal muscle 
tropomyosin (9, 55-57).  However, in the presence of 5 mM 
Mg  ++,  ~95  and  100% binding  of tropomyosins  1  and  2 
(estimated  from  the  staining  intensity  of tropomyosin  in 
supernatant and pellet on the gel), respectively, were observed, 
whereas the binding of tropomyosin 3 to F-actin reached only 
~75%  (Fig.  5,  lanes C  and D). When the  concentration  of 
Mg  ÷÷ in the binding solution was increased to  10 mM, the 
binding oftropomyosins 1, 2, and 3 was nearly complete (Fig. 
5, lanes E  and F). However, the increased amounts of tro- 
pomyosin in the pellet were not due to a simple precipitation 
of tropomyosin by Mg  ÷÷, because there was no precipitation 
of tropomyosin at  10  mM  Mg  ÷÷ (Fig.  5,  lanes G  and  H). 
Moreover, when the  binding experiment was performed at 
100 mM KCI in the absence of Mg  ÷÷, the extent of binding 
for tropomyosins 1 and 2 appeared to be greater than that for 
tropomyosin 3 (Fig. 5, lanes I and J). At 100 mM KCI and 5 
mM  Mg  ÷÷, the  binding  of tropomyosins  1 and  2  reached 
maximal, while only ~50% of tropomyosin 3 was bound to 
F-actin (in Fig. 5, lanes K and L). Therefore, it appears that 
the actin-binding property of tropomyosin 3 is quite different 
from that of tropomyosins 1 and 2. As reported for platelet 
tropomyosin (9),  troponin  I  also stimulated the binding of 
tropomyosins 1, 2, and 3 to F-actin (data not shown). 
DIMER  FORMATION  BY  TROPOMYOSlN  ISOFORMS:  It 
has been shown that rabbit skeletal tropomyosin in the native 
state can be intramolecularly cross-linked by DTNB or by air 
oxidation in the presence of Cu  ÷÷. The results suggest that 
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gel analyses  of tropomyosin isoforms pu- 
rified from chicken.  (A) Comparison  of 
CEF  tropomyosin  isoforms  (CEF) with 
muscle  isoforms  purified from  chicken 
heart (CH), gizzard (CG), and leg (CL). (B) 
CEF tropomyosin isoforms are resolved 
into seven polypeptides, i.e., a, b, c,  1, 
2,  3a, and  3b  on the two-dimensional 
gel with pH 4-6 ampholytes for the first 
dimension (IEF,  isoelectric focusing) and 
12.5% SDS polyacrylamide for the sec- 
ond dimension.  For unknown reasons, 
tropomyosins a,  b,  and  1  are  usually 
found to split into two molecular weight 
variants on two-dimensional gels. 
the tropomyosin dimer is arranged  in  register (27,  32,  52). 
Further analysis of the distribution of tropomyosin dimers in 
several muscle fibers revealed that tropomyosin dimers did 
not assemble randomly from c~ and  fl isoforms, but  rather 
that  c~  was  assembled  preferentially  in  vivo  (6).  It  was, 
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therefore, of interest to find out what types of tropomyosin 
dimers, i.e.,  homodimers or heterodimers, could be formed 
in CEF cells.  The information obtained could be useful in 
understanding the assembly of CEF tropomyosin. Therefore, 
we performed the cross-linking reaction both on purified CEF IEF 
q 
Acidic  basic 
A.~a 
~.CL  ~"b 
a-CL"~2 
CH',, o 
3b  ~  ",3a 
~Act in 
hGORe 3  A schematic representation of the tropomyosin isoforms 
from  chicken  on  two-dimensional gels. a-CL and  ~-CL, skeletal 
tropomyosin isoforms purified from chicken leg muscle; CH, cardiac 
tropomyosin isoform purified from chicken  heart muscle; a and c, 
smooth muscle tropomyosin isoforms purified from gizzard; a, b, c, 
1, 2, 3a, and 3b, tropomyosin isoforms purified from CEF cells. 
tropomyosin and on microfilaments by the DTNB method. 
In  contrast  to  air  oxidation,  the  DTNB  method  has been 
shown  to  be  an  efficient,  reproducible,  and  convenient 
method to cross-link tropomyosin into dimers (6,  32).  The 
cross-linked samples were solubilized in the gel sample buffer 
without reducing agents and  then  analyzed on  12.5% SDS 
polyacrylamide gels. As shown in Fig.  6, CEF tropomyosins 
formed at least three species of dimers, although some of the 
isoforms still remained in the monomer state (lanes 4 and 5). 
Under the  same conditions  for cross-linking,  both chicken 
cardiac and leg tropomyosin were completely dimerized (Fig. 
6, lanes 1 and 2). On the other hand, only part of the gizzard 
tropomyosin was in dimer form (Fig. 6, lane 3 and Fig. 7 C). 
The failure of the gizzard tropomyosin to cross-link well by 
the DTNB method has also been reported recently (34). The 
amino acid sequence derived from the  nucleotide sequence 
of a cDNA clone containing coding region for the fast com- 
ponent of gizzard tropomyosin (Helfman, D. M., J. R. Fer- 
amisco,  W.  M.  Ricci,  and  S.  H.  Hughes,  manuscript  in 
preparation) indicated that this gizzard tropomyosin did not 
contain cysteine residue at the position  190, which is impor- 
tant  for the  dimer formation.  In  striated tropomyosin, the 
localized chain  separation occurred  in  a  region  containing 
cysteine residue at position 190. This is presumably the basis 
for  the  dimer  formation  (34).  Furthermore,  the  apparent 
molecular weights of the cross-linked tropomyosins do  not 
correspond to those expected. This may be due to the abnor- 
mal mobility of tropomyosins on SDS polyacrylamide gels. 
To  identify  which  tropomyosin  isoforms  formed  which 
dimers, we subjected the cross-linked samples to two-dimen- 
sional SDS-PAGE with the first dimension run under oxidized 
conditions and the second dimension run under the reduced 
conditions.  Any proteins that did not form a  dimer should 
migrate along the diagonal of the two-dimensional gel. The 
dimers present in  the  first  dimension  of the  gel  should  be 
reduced to their monomer components off the diagonal line 
of the two-dimensional gel. Figs. 7 and 8 show the results of 
this type of analysis. In Fig. 7A, dimer species of/32, a2, and 
aB can be readily identified from the cross-linked sample of 
chicken leg tropomyosin. Because only one isoform of tro- 
pomyosin was found in  chicken cardiac  muscle, the  dimer 
species formed should be a2 (Fig. 7 B). In the case of gizzard 
tropomyosin, the  fast-migrating (f)  and  slow-migrating (s) 
components formed the dimer species of f2, sf, and s2 (Fig. 
7 C). As Fig.  8 shows,  CEF tropomyosin 1 formed a homo- 
FIGURE 4  SDS polyacrylamide gel analysis of the immunoprecipi- 
tare of cell-free translation products of CEF total poly(A)  ÷ RNA with 
rabbit  antiserum  against gizzard tropomyosin. Translational prod- 
ucts were labeled with  [3SS]methionine and  analyzed on  12.5% 
SDS polyacrylamide  gels. After electrophoresis, the gels were proc- 
essed for fluorography.  (A), The immunoprecipitate; (B) total cell- 
free translational products. CEF tropomyosin isoforms are indicated. 
dimer, although some was left in the monomer state. Tropo- 
myosin 3 also formed a dimer. At the present time, we do not 
know whether tropomyosin 3a or 3b formed individual hom- 
odimers or  both  of them  formed a  heterodimer.  Another 
dimer species was also formed by tropomyosin a and c. The 
evidence that indicates that tropomyosin c rather than  1 is 
involved in the formation of this dimer is indirect. Namely, 
the  molecular weight of this dimer species was identical to 
that of the  sf dimer formed from gizzard tropomyosin and 
tropomyosin a and c appear to be identical to the s and f of 
gizzard tropomyosin. Tropomyosin 2, either from the purified 
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binding ability of  CEF  tropomy- 
osin  isoforms.  Actin  and  tropo- 
myosin  were  mixed  in  a  buffer 
solution of  10  mM  Tris,  pH  8.0, 
and  0.2  mM  DTT,  containing 
either (A and B) 30 mM  KCI,  no 
Mg  ++,  (C and  D)  30  mM  KCl,  5 
mM Mg  +÷, (E and F) 30 mM  KCI, 
10  mM  Mg  ÷+, (I and /)  100  mM 
KCI,  no  Mg  ++,  or  (K and  L)  100 
mM KCI, 5 mM Mg  ÷+. The sample 
for lanes G and H  was tropomy- 
osin alone at 30 mM KCI and  10 
mM Mg  +÷. After incubation for 30 
min  at  room  temperature,  the 
protein samples were centrifuged 
for 30 min in a  Beckman airfuge 
rotor A-100/18 at 26 psi. Aliquots 
of  the  resulting  supernatants 
(lanes  A,  C,  E,  C,  I,  and  K)  and 
pellets (lanes B, D, F, H, J, and L) 
were  analyzed  on  12.5%  SDS 
polyacrylamide gels.  CEF  tropo- 
myosins are indicated by 1, 2, and 
3.  Tropomyosins a and b  cannot 
be  distinguished  from  the  actin 
band in this experiment. 
tropomyosin fraction or from the isolated microfilament frac- 
tion, did not form any dimer. 
Changes in Tropomyosin Isoform Expression in 
RSV-transformed CEE Cells 
We have isolated the tropomyosin-enriched microfilaments 
from normal and RSV-transformed CEF cells and analyzed 
their protein components on one- and two-dimensional gels. 
Fig. 9 shows the protein profiles of  the isolated microfilaments 
from normal and RSV-transformed CEF cells. In agreement 
with the report by Hendricks and Weintraub (24), tropomy- 
osins 1 and 2 were found to be decreased in the microfilaments 
isolated from RSV-transformed cells  (Fig.  9,  lane  1),  when 
compared with that from normal CEF cells (Fig. 9,  lane 2). 
The  relative decrease  in  tropomyosins  1 and  2  was  more 
obvious in the Coomassie Blue-stained gel (Fig. 9B), suggest- 
ing that the steady-state levels of tropomyosin l  and 2 were 
reduced. However, in the autoradiogram (Fig. 9A), the level 
of tropomyosin I was also decreased, although there was no 
apparent change in the amount of tropomyosin 2. In contrast 
to these decreases, tropomyosin 3  was found to be greatly 
increased in the microfilaments of RSV-transformed cells. To 
quantitatively examine these changes in tropomyosin isoform 
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expression upon transformation of CEF cells,  we estimated 
ratios of tropomyosins  1, 2,  and  3 to  100 parts of actin by 
measuring radioactivities of [35S]methionine  incorporated in 
each protein in isolated microfilaments as described in Ma- 
terials and Methods. As can be seen in Table II, normal CEF 
cell microfilaments have 8.9 parts of tropomyosin l, 6.7 parts 
of tropomyosin 2, and 2.0 parts oftropomyosin 3 to 100 parts 
of actin.  Upon transformation by RSV, the level  of tropo- 
myosin 1 was decreased more than 2.5 times, but the level of 
tropomyosin 3 was increased threefold.  It should  be  noted 
that the recovery of microfilaments from RSV-transformed 
cells was less than that from normal CEF cells. Approximately 
30  and  11%  of the  total  cell  actin  was  recovered in  the 
microfilaments isolated from normal and transformed cells, 
respectively. As estimated  by two-dimensional gel  analysis, 
the  microfilaments  isolated  from  both  normal  and  trans- 
formed cells contained >90% of the total cell tropomyosins. 
Therefore, the total amount of tropomyosin in transformed 
cell was reduced significantly. 
To examine more completely the changes in tropomyosin 
isoforms upon transformation, we analyzed the isolated mi- 
crofilaments on two-dimensional gels to resolve all forms of 
tropomyosin. As shown in  Fig.  10B,  in addition  to the de- 
crease in the amounts of tropomyosin 1 and 2, tropomyosins FIGURE 6  SDS polyacrylamide  gel analysis  of cross-linked samples. 
Tropomyosins  purified from chicken  heart  (lane  1),  leg (lane  2), 
gizzard  (lane 3),  and  CEF  cells  (lane 4),  and  the  microfilaments 
isolated from CEF cells (lane 5) were intramolecularly cross-linked 
by oxidation of opposing cysteines with  DTNB. The cross-linked 
samples were solubilized in gel sample buffer without the reducing 
agents and analyzed on 12.5% SDS polyacrylamide gels. 
a, b, and c appear to be undetectable  in the transformed  cell 
microfilaments.  However, both tropomyosin 3a and 3b are 
greatly  increased.  The  identical  pattern  of changes  in  the 
tropomyosin isoforms were also found in the total  lysates of 
transformed  cells (data not shown). 
DISCUSSION 
CEF tropomyosin has been identified  and isolated  to a high 
degree of purity. The purification  procedure described here is 
suitable  for  purifying  tropomyosin  from  various  types  of 
cultured  cells.  Taking into account the impurities  after the 
final  step  of purification,  we estimated that  the amounts of 
FIGURE 7  Identification of dimer  species formed  from  chicken 
muscle tropomyosin by modified two-dimensional gel electropho- 
resis. Tropomyosin purified from  chicken  leg  (A), heart  (B), and 
gizzard (C) was intramolecularly cross-linked  by oxidation of op- 
posing cysteines with DTNB. The cross-linked samples were then 
subjected to 12.5% SDS polyacrylamide gel electrophoresis under 
the oxidized condition as the first  dimension (from  right  to left). 
12.5% SDS  PAGE in the second dimension (from top to bottom) 
was  performed  under  the  reduced  condition.  Proteins  having 
formed dimers would be expected to run off the diagonal line (line 
in each gel) after the reduction in the second dimension.  Arrow- 
heads indicate the positions for the molecular weight markers. The 
molecular weight marker proteins are identical to those used in Fig. 
1. a and /~ in A indicate a- and/~-tropomyosin of chicken  skeletal 
muscle, a in B indicates a-tropomyosin of cardiac muscle, s and f 
in C indicate the slow- and fast-migrating components of gizzard 
tropomyosin. 
LtN ET ^L.  Tropomyosin Isoforms  in Chicken Embryo Fibroblasts  699 FIGURE 8  Identification of dimer species formed from CEF tropomyosin by modified two-dimensional gel electrophoresis. CEF 
tropomyosin (A) and the isolated microfilaments  (B) were intramolecularly cross-linked by oxidation of opposing cysteines with 
DTNB. The cross-linked  samples were then subjected  to a modified two-dimensional gel electrophoresis,  as described  in the 
legend of Fig. 7.  Proteins that have formed dimers  would be  expected to  run  off the diagonal  line (line  in  each gel). CEF 
tropornyosin isoforms are  indicated.  H  and  L indicate the heavy and  light  chains of the LCK16 IgM  monoclonal antibody. 
Arrowheads  indicate the positions  of the molecular weight markers (M, x  10-3). The  molecular weight marker  proteins  are 
identical to those used in Fig. 1. 
CEF tropomyosin obtained were 1.4% of  the total cell protein. 
The purified tropomyosin is composed of seven isoforms, i.e., 
a,  b,  c,  1,  2,  3a,  and  3b,  which  can  be separated by two- 
dimensional  gels.  Tropomyosins  1 (38,000  mol  wt)  and  2 
(36,500 tool wt) are considered the major forms, and tropo- 
myosins a (45,000 mol wt), b (43,000 tool wt), c (38,000  moi 
wt), 3a (32,800 tool wt), and 3b (32,800 mol wt) are consid- 
ered minor forms. Earlier studies on the identification of CEF 
tropomyosin with rabbit antiserum against muscle tropomy- 
osin  have  detected  two  proteins  with  apparent  molecular 
weights of 35,000 and 33,000 (24,  40).  These are equivalent 
to tropomyosins 1 and 2  described here. The lack of cross- 
reaction of  antibodies used by these groups might hinder them 
from detecting the minor forms oftropomyosin. In the present 
and previous studies, we have carried out the purification of 
tropomyosin and the isolation of microfilaments from CEF 
cells  (37).  Both  experiments  were  designed  to  enrich  the 
tropomyosin isoforms, particularly the minor forms, in  the 
isolated fractions. Therefore, with the help of polyclonal and 
monoclonal antibodies against tropomyosin, we were able to 
detect seven isoforms of tropomyosin from CEF cells. 
The results from cell-free translation of total CEF poly(A)  ÷ 
RNAs, pulse-chase labeling experiments, and [32P]phosphate 
labeling experiments strongly argue against the possibility that 
CEF tropomyosin isoforms resulted simply from posttransla- 
tional  modifications.  Furthermore,  the  cell-free  translation 
results suggest that at least seven mRNAs are present for these 
multiple forms of tropomyosin. Whether these tropomyosin 
isoforms represent the products of different genes remains to 
be determined. 
Tropomyosins a  and  c  exhibit mobilities on  two-dimen- 
sional gels that are identical to the slow-  and fast-migrating 
components of gizzard tropomyosin. This may indicate con- 
tamination by a small population of smooth muscle cells in 
our CEF preparation. Alternatively, CEF cells prepared here 
may indeed express trace, but significant, amounts of gizzard 
forms of tropomyosin. At the present time, we are unable to 
distinguish between these two possibilities.  However, because 
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neither skeletal muscle nor cardiac muscle forms of tropo- 
myosin can be detected in  CEF tropomyosin, it is unlikely 
that there was contamination of striated muscle cells in our 
CEF preparation. 
In addition  to CEF cells,  multiple forms of tropomyosin 
have  also  been  found  in  many  cultured  nonmuscle  cells, 
including human fibroblasts (21,  38,  53),  mouse fibroblasts 
(38,  49),  and rat embryo cells  (41,  49).  The significance of 
these multiple forms of tropomyosin is not yet understood. 
However,  it  is  possible  that  the  presence  of tropomyosin 
isoforms in a cell may reflect regulatory mechanisms tor the 
numerous discrete functions of microfilaments, such as the 
maintenance  of cell  shape,  membrane ruffling,  cell  move- 
ment,  and  formation  of cleavage  furrows  during  mitosis. 
Knowledge concerning the intracellular assembly (or localiza- 
tion) and the biochemical properties of individual isoforms 
may allow us to evaluate this regulatory function  of tropo- 
myosin. To this end, two experiments, i.e., dimer formation 
and the actin-binding abilities of tropomyosin isoforms, have 
been carried out in the present report. 
Analysis of tropomyosin dimer species reveals that tropo- 
myosin l, and probably 3, can form individual homodimers 
by the oxidation of opposing cysteine residues on the mole- 
cule, whereas under the same conditions, tropomyosins a and 
c form a  heterodimer. The identical dimer species  were ob- 
tained from the oxidation of both the purified tropomyosin 
fraction and the isolated micro  filament fraction. In the latter 
fraction,  tropomyosin  isoforms  are  associated  with  native 
actin filaments (38).  Therefore, it is likely that homodimers 
formed by tropomyosin 1 or 3 and heterodimers formed by 
tropomyosins a and c do indeed reflect the in vivo assembly 
of these isoforms. However, although both cardiac and skel- 
etal muscle tropomyosins form dimers completely under the 
condition used for oxidation, there are some populations of 
tropomyosins 1 and 3 and all of tropomyosin 2 that remain 
in their monomer state. One possible explanation is that either 
there are no cysteine residues on these tropomyosins or cys- 
teine residues are already oxidized during isolation. Alterna- FIGURE 9  SDS polyacrylamide gel analysis of the microfilaments isolated from normal and RSV-transformed CEF cells. Normal 
and RSV-transformed CEF cells were labeled with [3SS]methionine  and subjected to microfilament isolation. An equivalent  amount 
of each microfilament were analyzed on  12.5% SDS polyacrylamide gels. (A) Autoradiogram; (B) Coomassie Blue-stained  gel 
profile. (Lanes 1) The microfilaments from RSV-transformed CEF cells; (lanes  2) the microfilaments  from normal CEF cells. CEF 
tropomyosin isoforms are indicated by I, 2, and 3. H and L indicate the heavy and light chains of LCK16 IgM antibody. 
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Radioactive Ratios* of Tropomyosin  Isoforms to Actin in Tropo- 
myosin-enriched  Microfilaments  Isolated from Normal and RSV- 
transformed CEF 
Normal CEF  RSV-transformed CEF 
Aver-  Aver- 
II  age  I  II  age 
Act in  100  100  100  100  100  100 
Tropomyosins 
1 (38K)  8.8  9.0  8.9  3.2  3.8  3.5 
2 (36.5K)  6.3  7.1  6.7  6.4  7.9  7.1 
3 (32.8K)  1.4  2.6  2.0  6.2  5.4  5.8 
* Values were  calculated  from  [3SS]methionine  incorporation  into each  pro- 
tein band of the  isolated  microfilaments  separated  on SDS polyacrylamide 
gels. (K, x103.) 
FIGURE  10  Two-dimensional  gel  analysis  of  the  microfilaments 
isolated  from  normal  and  RSV-transformed  CEF  cells.  Microfil- 
aments were isolated from  [3SS]methionine-labeled normal (A) and 
RSV-transformed  (B)  CEF  cells  and  analyzed  by two-dimensional 
gel electrophoresis. Fluorographs of a portion of the gels are shown 
with the acidic ends to the left. CEF tropomyosin isoforms are a, b, 
c,  I, 2,  3a,  and  3b.  Tropomyosin  isoforms  1 and  2  were  greatly 
reduced and tropomyosins 3a and 3b were increased in the trans- 
formed  cell  microfilaments  as  compared  to  those  in  normal cell 
microfilaments. 
Lively, it is possible that tropomyosin 2 have formed hetero- 
dimer in vivo with either tropomyosin  1 or 3.  Because the 
positions of cysteine residues  on  these  isoforms are  out of 
register, no dimers can be detected by the present cross-linking 
method. Isoform-specific monoclonal antibodies may provide 
useful  reagents  for studying the  intracellular  assembly  and 
localization of individual isoforms. 
It has been  shown that the binding of nonmuscle tropo- 
myosin to rabbit  F-actin is weaker than  that of muscle tro- 
pomyosin (9,  19).  In this paper, a  direct comparison of the 
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actin-binding abilities of CEF tropomyosin isoforms has been 
made. With 100 mM KC1 and no Mg  ++, tropomyosin 3 binds 
poorly to F-actin, while >85%  of tropomyosins 1 and 2 are 
bound  to  actin  under  these  conditions.  This  difference  in 
actin  binding may be  of importance  with  respect to the  in 
vivo functions of  individual isoforms. Results from numerous 
studies have suggested that tropomyosin may play a  role in 
stabilizing and protecting actin  filaments in the cell  (3,  16, 
20, 29, 33, 43). Therefore, it is possible that different isoforms 
of tropomyosin with different actin-bind abilities would have 
different extents ofactin filament stabilization and protection. 
That is, tropomyosins 1 and 2 are more effective in stabilizing 
and  protecting  actin  microfilaments  than  tropomyosin  3. 
Because transformed cells had more disrupted microfilaments 
(14,  15, 22, 23, 48), one would expect to find a  reduction in 
levels oftropomyosins 1 and 2, concomitant with an increased 
synthesis of tropomyosin 3, in RSV-transformed CEF cells. 
Indeed, we have observed this type of change in tropomyosin 
isoforms upon cell transformation (Figs.  9 and 10). 
We would like to thank Dr. J. D. Watson for his enthusiastic support 
of this work. We are grateful to Drs. M. Solursh, N. Williams, and 
D. Soil for their  invaluable  suggestions and critical reading of the 
manuscript.  The able assistance of N.  Haffner and J.  L.-C. Lin  is 
gratefully acknowledged. 
This work was supported  by a National  Institute of Health grant 
GM34105 and by a grant from the Muscular Dystrophy Association. 
Received for publication  29 August  1984, and  in revised form  29 
October 1984. 
NoteAdded in Proof."  After this manuscript was accepted, Hendricks 
and Weintraub (Hendricks, M., and H. Weintraub,  1984, Mol. Cell. 
Biol., 4:1823-1833) reported that CEF cells contained seven distinct 
tropomyosin  isoforms and that the differential expression of these 
tropomyosin isoforms was found in RSV-transformed CEF cells. 
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